Dr. Xiao to Present at the 43rd Annual J.P. Morgan Healthcare Conference and the 8th Annual BFC Global Healthcare BD & Investment Conference.
The company's roadshow is scheduled to take place on Sunday, January 12, 2025, at 3:45 PM at The St. Regis Hotel, San Francisco.

Dr. Xiao attended the 8th Advanced Therapy Innovation Summit (ATMP2024) and delivered a presentation on the engineered cell-targeted LNP platform of MagicRNA.

Dr. Zha was invited to attend the Yimao BioChina South China Conference, where he delivered a presentation titled Research and Development of the Engineered Cell-Targeted Delivery Platform (EnC-LNP).

Dr. Zha was invited to attend the I-RNA 4th Deep Focus Summit on Nucleic Acid Drug Industry and delivered a keynote speech titled Industrialization of Novel High-Efficiency, Low-Toxicity Ionizable Amino Lipids and Research and Development of Engineered Cell-Targeted Delivery Platforms'.

Dr. Cha was invited to attend the 2024 Nucleic Acid and mRNA Vaccine Industry Forum, where he delivered a keynote speech titled Industrialization of Novel High-Efficiency, Low-Toxicity Ionizable Amino Lipids and Research and Development of Engineered Cell-Targeted Delivery Platforms. Additionally, he participated in a roundtable discussion with Wang Haomeng, Deputy General Manager of CanSino Biologics, and Professor Kong Na from Zhejiang University, on the topic of 'The New Therapeutic Revolution Brought by mRNA Technology and the Next-Generation mRNA Technology and R&D Trends.'